Your browser doesn't support javascript.
loading
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective.
Barry, Aisling; Apisarnthanarax, Smith; O'Kane, Grainne M; Sapisochin, Gonzalo; Beecroft, Robert; Salem, Riad; Yoon, Sang Min; Lim, Young-Suk; Bridgewater, John; Davidson, Brian; Scorsetti, Marta; Solbiati, Luigi; Diehl, Adam; Schuffenegger, Pablo Munoz; Sham, Jonathan G; Cavallucci, David; Galvin, Zita; Dawson, Laura A; Hawkins, Maria A.
Affiliation
  • Barry A; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada. Electronic address: aisling.barry@rmp.uhn.ca.
  • Apisarnthanarax S; Seattle Cancer Care Alliance, and Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
  • O'Kane GM; Department of Medical Oncology and Haematology, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Sapisochin G; Princess Margaret Cancer Centre, and Department of Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Beecroft R; Department of Medical Imaging, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Salem R; Department of Interventional Radiology, Northwestern University, Chicago, IL, USA.
  • Yoon SM; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lim YS; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Bridgewater J; UCL Cancer Institute, University College London, London, UK.
  • Davidson B; Department of Surgical Biotechnology, UCL Division of Surgery and Interventional Science, University College London, London, UK.
  • Scorsetti M; Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Solbiati L; Radiology Department, Humanitas Clinical and Research Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Diehl A; Department of Medical Oncology, University of Washington, Seattle, WA, USA.
  • Schuffenegger PM; Radiation Oncology Unit, Department of Hematology Oncology, Pontifical Catholic University of Chile, Santiago, Chile.
  • Sham JG; Department of Surgery, University of Washington, Seattle, WA, USA.
  • Cavallucci D; Department of Surgery, Royal Brisbane and Women's Hospital, University of Queensland, Brisbane, QLD, Australia.
  • Galvin Z; Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Dawson LA; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Hawkins MA; UCL Cancer Institute, University College London, London, UK; Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
Lancet Gastroenterol Hepatol ; 5(8): 765-775, 2020 08.
Article in En | MEDLINE | ID: mdl-32511951
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Carcinoma, Hepatocellular / Pandemics / Liver Neoplasms Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Gastroenterol Hepatol Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Carcinoma, Hepatocellular / Pandemics / Liver Neoplasms Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Gastroenterol Hepatol Year: 2020 Document type: Article Country of publication: